Agglutination of Platelet-Type von Willebrand’s Disease Platelets by Bovine von Willebrand Factor

Summary

It has been shown that platelets from patients with platelet- type von Willebrand’s disease (vWD) agglutinate upon the addition of human von Willebrand factor (vWF) in the absence of ristocetin or botrocetin, suggesting that platelet membrane receptors for human vWF is abnormal. The present work reports the platelet agglutinability on stimulation with bovine vWF in platelet-type vWD. Platelets in patient platelet-rich plasma or washed platelet suspensions and patient platelets treated with formalin agglutinated in the presence of markedly lower concentrations of bovine vWF than those required for normal platelets. This finding provides additional evidence that platelet-type vWD platelets have abnormal expression of binding sites for vWF on their surface, and supports that platelet receptors for bovine vWF are identical or very close to those for human vWF.

Keywords

Platelet-type von Willebrand’s disease - von Willebrand factor - Bovine von Willebrand factor - Platelet agglutination - Receptor

• References

• 1 Takahashi H, Sakuragawa N, Shibata A. von Willebrand disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein. Am J Hematol 1980; 8: 299-308
• 2 Takahashi H. Studies on the pathophysiology and treatment of von Willebrand’s disease. IV Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand’s disease. Thromb Res 1980; 19: 857-867
• 3 Takahashi H, Nagayama R, Hattori A, Ihzumi T, Tsukada T, Shibata A. von Willebrand disease associated with familial thrombocytopenia and increased ristocetin-induced platelet aggregation. Am J Hematol 1981 10: 80-99
• 4 Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma J-P, Vicic WJ, Rogers J. Pseudo-von Willebrand’s disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers N Engl J Med 1982; 306: 326-333
• 5 Miller JL, Castella A. Platelet-type von Willebrand’s disease: Characterization of a new bleeding disorder. Blood 1982; 60: 790-794
• 6 Takahashi H, Handa M, Watanabe K, Ando Y, Nagayama R, Hattori A, Shibata A, Federici AB, Ruggeri ZM, Zimmermann TS. Further characterization of platelet-type von Willebrand’s disease in Japan. Blood 1984; 64: 1254-1262
• 7 Miller JL, Kupinski JM, Castella A, Ruggeri ZM. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest 1983; 72: 1532-1542
• 8 Takahashi H, Shibata A. Agglutination of formalin-fixed, platelet-type von Willebrand’s disease platelets by human von Willebrand factor. Thromb Haemostas 1984; 52: 267-270
• 9 Takahashi H, Nagayama R, Hattori A, Shibata A. Botrocetin- and Polybrene-induced platelet aggregation in platelet-type von Willebrand disease. Am J Hematol. 1985 18. (in press)
• 10 Forbes CD, Prentice CR M. Aggregation of human platelets by purified porcine and bovine antihaemophilic factor. Nature 1973; 241: 149-151
• 11 Griggs TR, Cooper HA, Webster WP, Wagner RH, Brinkhous KM. Plasma aggregating factor (bovine) for human platelets: A marker for study of anti-hemophilic and von Willebrand factors. Proc Natl Acad Sci USA 1973; 70: 2814-2818
• 12 Kirby EP, Mills DC B. The interaction of bovine factor VIII with human platelets. J Clin Invest 1975; 56: 491-502
• 13 Cooper HA, Clemetson KJ, Lüscher EF. Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): An integral membrane glycoprotein. Proc Natl Acad Sci USA 1979; 76: 1069-1073
• 14 Kao K-J, Pizzo SV, McKee PA. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets. J Clin Invest 1979; 63: 656-664
• 15 Kao K-J, Pizzo SV, McKee PA. Platelet receptors for human factor VIII/von Willebrand factor protein: Functional correlation of receptor occupancy and ristocetin-induced platelet aggregation. Proc Natl Acad Sci USA 1979; 76: 5317-5320
• 16 Read MS, Shermer RW, Brinkhous KM. Venom coagglutinin: An activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 1978; 75: 4514-4518
• 17 Moake JL, Olson JD, Troll JH, Tang SS, Funicella T, Peterson DM. Binding of radioiodinated human von Willebrand factor to Bemard-Soulier, thrombasthenic and von Willebrand’s disease platelets. Thromb Res 1980; 19: 21-27
• 18 Nurden AT, Dupuis D, Kunicki TJ, Caen JP. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest 1981; 67: 1431-1440
• 19 Okumura T, Jamieson GA. Platelet glycocalicin: A single receptor for platelet aggregation induced by thrombin or ristocetin. Thromb Res 1976; 8: 701-706
• 20 Solum NO, Hagen I, Gjemdal T. Platelet membrane glycoproteins and the interaction between bovine factor VIII-related protein and human platelets. Thromb Haemostas 1977; 38: 914-923
• 21 Solum NO, Hagen I, Peterka M, Gjemdal T. Absence of the 145000 molecular weight, soluble platelet membrane glycoprotein - Lack of platelet agglutination. Thromb Haemostas 1979; 42: 1626-1629
• 22 Suzuki K, Nishioka J, Hashimoto S. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor. Thromb Res 1980; 17: 215-223
• 23 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110
• 24 Clemetson KJ. Platelet membrane glycoprotein I: Structure and function. The domain of glycoprotein I involved in the von Willebrand receptor Blood Cells 1983; 9: 319-329
• 25 Born GV R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
• 26 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
• 27 Hardisty RM, Macpherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thrombos Diathes Haemorrh 1962; 7: 215-229
• 28 Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thrombos Diathes Haemorrh 1975; 34: 306-308
• 29 Holme S, Murphy S. Influence of platelet count and size on aggregation studies. J Lab Clin Med 1981; 97: 623-630
• 30 Miller JL, Boselli BD, Kupinski JM. In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand’s disease. Blood 1984; 63: 226-230